Technology

Diffusion Pharmaceuticals

$1.08
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.01 (+0.93%) As of 3:57 PM UTC today

Why Robinhood?

You can buy or sell DFFN and other stocks, options, and ETFs commission-free!

About DFFN

Diffusion Pharmaceuticals Inc. Common Stock, also called Diffusion Pharmaceuticals, is a clinical stage company, which engages in the development of treatment for life threatening conditions. It offers Trans Sodium Crocetinate. The company was founded by David G. Kalergis and John L. Gainer in 2001 and is headquartered in Charlottesville, VA. The listed name for DFFN is Diffusion Pharmaceuticals Inc. Common Stock.

CEO
Robert J. Cobuzzi
Employees
10
Headquarters
Charlottesville, Virginia
Founded
2001
Market Cap
75.12M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
5.81M
High Today
$1.16
Low Today
$1.07
Open Price
$1.15
Volume
1.39M
52 Week High
$1.60
52 Week Low
$0.25

Collections

DFFN Earnings

-$0.63
-$0.34
-$0.04
$0.25
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 17, After Hours

You May Also Like

DOX
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure